Clenbuterol Increases Lean Muscle Mass but Not Endurance in Patients With Chronic Heart Failure

Journal of Heart and Lung Transplantation

Volumn 27, Issue 4, 2008, Pages 457-461

  Kamalakkannan, Gayathri ^a   Petrilli, Christopher M ^a   George, Isaac ^b   LaManca, John ^c   McLaughlin, Brooke T ^b   Shane, Elizabeth ^b   Mancini, Donna M ^b   Maybaum, Simon ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b Columbia College of Physicians and Surgeons ^*  (United States)

^c SALISBURY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLENBUTEROL; FAT; METOPROLOL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN TISSUE; LEAN BODY WEIGHT; MALE; MUSCLE CRAMP; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; TREMOR;

ADRENERGIC BETA-AGONISTS; ADULT; BODY COMPOSITION; CHRONIC DISEASE; CLENBUTEROL; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART; HEART FAILURE; HUMANS; LUNG; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; RESPIRATORY MUSCLES;

EID: 40949107952     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.01.013     Document Type: Article

References (25)

1. Gibbs J.S.R., Keegan J., Wright C., Fox K.M., and Poole-Wilson P.A. Pulmonary artery changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol 15 (1990) 52-61
2. Wilson J.R., Martin J.L., and Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: Role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 53 (1984) 1308-1315
3. Savin W.M., Haskell W.L., Schroeder J.S., and Stinson E.B. Cardiopulmonary responses of cardiac transplant to graded symptom limited exercise. Circulation 62 (1980) 55-60
4. Sullivan M.J., Green H.G., and Cobb F.R. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81 (1990) 518-527
5. Massie B., Conway M., Yonge R., et al. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 76 (1987) 1009-1019
6. Lipkin D.P., Jones D.A., Round J.M., and Poole-Wilson P.A. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 18 (1988) 187-195
7. Chua T.P., Anker S.D., Harrington D., and Coats A.J.S. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. Br Heart J 74 (1995) 381-385
8. Opasich C., Ambrosino N., Felicetti G., et al. Heart failure related myopathy. Clinical and pathophysiological insights. Eur Heart J 20 (1999) 1191-1200
9. Magnusson G., Gordon A., Kaijser L., et al. High intensity knee extensor training, in patients with chronic heart failure. Major skeletal muscle improvement. Eur Heart J 17 (1996) 1048-1055
10. Martineau L., Horan M., Rothwell N.J., and Little R.A. Salbutamol a b2-adrenoreceptor agonist, increases skeletal muscle strength in young men. Clin Sci 83 (1992) 615-621
11. Di Gioacchino M., Mezzetti A., Mancini M., et al. Study of the cardiovascular effects of clenbuterol in exercise-induced asthma. Respiration 51 (1987) 205-213
12. Pasotti C., Capra A., and Vibelli C. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial. Int J Clin Pharmacol Biopharm 17 (1979) 176-180
13. Pasotti C., Gandolfi P., and Vibelli C. Cardiovascular responses in normal man to beta adrenergic stimulation with clenbuterol (NAB 365). Curr Ther Res 28 (1980) 235
14. Beckett A.H. Clenbuterol and sport. [letter]. Lancet 340 (1992) 1165
15. Perry H. Clenbuterol: a medal in tablet form?. [letter]. Br J Sp Med 27 (1993) 141
16. Maltin C.A., Delday M.I., Watson J.S., et al. Clenbuterol, a beta-adrenoreceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci 84 (1993) 651-654
17. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355 (2006) 1873-1884
18. George I., Xydas S., Mancini D.M., et al. Effect of CLEN on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant 25 (2006) 1084-1090
19. Warren M.P., and Constantini N.E. Sports endocrinology (2000), Humana Press, Totowa, NJ
20. Devereux R., and Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55 (1977) 613-618
21. Rector T.S., Kubo S.H., and Cohn J.N. Patients' self-assessment of their congestive heart failure. Part 2: Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Fail (1987) 198-209
22. Harridge S.D., Magnusson G., and Gordon A. Skeletal muscle contractile characteristics and fatigue resistance in patients with chronic heart failure. Eur Heart J 17 (1996) 896-901
23. Gosker H.R., Wouters E.F.M., Can Der Vusse G.J., and Schols A.M.W.J. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71 (2000) 1033-1047
24. Hayes A. Williams DA. Contractile properties of clenbuterol-treated mdx muscle are enhanced by low-intensity swimming. J Appl Physiol 82 (1997) 435-439
25. Petrou M., Clarke S., Morrison K., Bowles C., Dunn M., and Yacoub M.H. CLEN increases stroke power and contractile speed of skeletal muscle for cardiac assist. Circulation 99 (1999) 713-720